The "World Orphan Drug Congress Europe" is a leading specialist congress that specializes in advances in the treatment of rare diseases. This event takes place at different locations every year and attracts experts from the fields of pharmacy, biotechnology, regulatory authorities, patient representatives and investors. The congress is organized by Terrapinn Inc. and attracts participants from all over the world. The "World Orphan Drug Congress" serves as a platform to promote access to and development of drugs for rare diseases. It is known for presenting innovative therapies and technologies and has established itself as a central meeting place for global exchange and networking. Thematically, the congress covers areas such as genetic therapies, clinical development, market strategies and the production of advanced therapies. Special attention is paid to the latest developments in rare oncology, cell and gene therapy, genetic testing and genetic engineering. The congress will also present advanced therapeutic and diagnostic procedures that are of great importance for the treatment and research of rare diseases. Innovative services in the areas of clinical trials, market access and patient advocacy will be presented. The congress attracts a diverse group of participants, including leading pharmaceutical companies, biotechnologists, government representatives and patient organizations. The main visitors are researchers, medical professionals and business leaders who specialize in the development of new therapies for rare diseases. With its specific focus and the unique gathering of experts from all over the world, the "World Orphan Drug Congress Europe" is an unmissable event for everyone dedicated to the research and treatment of rare diseases. The World Orphan Drug Congress Europe will take place on 2 days from Tuesday, 28. October to Wednesday, 29. October 2025 in Amsterdam.